Internal Medicine Doctors in Austell, GA Accepting Medicare
109 Internal Medicine doctors found. Showing 101 - 109
 Uno Barcelli, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1660 Mulkey Rd, Suite B, Austell, GA 30106 Phone: 678-460-2700 Fax: 770-739-0212 |
Dr. Steven L Cohen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1790 Mulkey Rd, Suite 5 A, Austell, GA 30106 Phone: 770-732-1055 Fax: 770-732-0175 |
Dr. Christopher Florian Stanke, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3825 Medical Park Dr Ste 100, Austell, GA 30106 Phone: 470-267-1760 |
Dr. Aristidis Iatridis, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3820 Medical Park Dr, Suite A, Austell, GA 30106 Phone: 770-948-6041 Fax: 770-739-5411 |
Dr. C David Markle, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1599 Mulkey Rd, Austell, GA 30106 Phone: 770-948-4455 Fax: 770-819-8824 |
 Quintesia L Grant, MD/PHD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4040 Hospital West Dr, Austell, GA 30106 Phone: 770-793-7899 Fax: 770-793-7856 |
Claudia Fotzeu Toukam, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1790 Mulkey Rd Ste 5a, Austell, GA 30106 Phone: 404-265-1044 |
Nnaemezie Emmanuel Odioemene, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1660 Mulkey Rd, Ste B, Austell, GA 30106 Phone: 267-266-4959 |
Dr. Clifford Pickett, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1680 Hospital South Dr, Austell, GA 30106 Phone: 770-732-3880 Fax: 770-732-2229 |
News Archive
New drug combination may be effective against malignant melanoma
A team of Massachusetts General Hospital investigators has discovered a new combination of drugs that may be effective against one of the deadliest cancers, malignant melanoma. The combination - pairing a drug targeted against mutations in the BRAF gene with a second drug that targets another important signaling pathway - was discovered through one of the largest screens of cancer drug combinations conducted to date.
US FDA approves raxibacumab for treating inhalational anthrax
The US Food and Drug Administration have approved the monoclonal antibody raxibacumab for treatment of inhalational anthrax, caused by breathing in spores of Bacillus anthracis.
Clinical study shows positive effects of CAD106 vaccine against AD
A study led by Karolinska Institutet in Sweden reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL
ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.
› Verified 7 days ago
Internal Medicine
Emergency Medicine
Obstetrics & Gynecology
Orthopaedic Surgery
Family Medicine
Pediatrics
Pulmonary Disease
Psychiatry & Neurology
Surgery
Anesthesiology
Cardiovascular Disease
Nephrology